ReleaseWire Connect

Ralph A. DeFronzo, MD, Professor of Medicine and Chief of the Diabetes Division at the University of Texas Health Science Center and the Audie L. Murphy Memorial VA Hospital in San Antonio, Texas), will be giving a presentation entitled “Treatment of T2DM Should be Based on Established Pathophysiologic Abnormalities” at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC.

Peter T. Lomedico, Director of Industry Partnerships, Cure Therapies at Juvenile Diabetes Research Foundation [JDRF] will participate in the panel discussion called “Partnering with Non-Profits” at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC.

Andrew Merron Ph.D., Biosimilars Advisory Service Product Director at BioTrends (a Decision Resources Company), will be giving a featured presentation entitled “Biosimilar Opportunity within the Insulin Market” at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC.

Vice Presidents and Directors of Big Pharmas – Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Merck, Novartis, Novo Nordis, Pfizer, Roche, Sanofi and many more will speak at the 2nd Diabetes Summit (April 19-20, 2012 in Boston, MA).

Peter T. Lomedico, Director of Industry Partnerships, Cure Therapies at Juvenile Diabetes Research Foundation [JDRF] will participate in the panel discussion called “Partnering with Non-Profits” at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC.

Brock Reeve, Executive Director, Stem Cell & Cancer Research Institute, Harvard Stem Cell Institute to give a Featured Presentation on “The Latest From The Lab” at the 8th Stem Cell Summit (April 19-20, 2012 in Boston, MA)

Tiina Palomäki, Safety Working Party & Cell Products Working Party, European Medicines Agency & Finnish Medicines Agency to give a Featured Presentation on “Regulatory Requirements for Stem Cell-based Medicinal Products in the EU” at the 8th Stem Cell Summit (April 19-20, 2012 in Boston, MA)

Glen Prestwich, Presidential Professor, Director,Therapeutic Biomaterials Center, Special Presidential Assistant for Faculty Entrepreneurism, Department of Medicinal Chemistry at University of Utah to give a Keynote Presentation on “Clinical Biomaterials for Regenerative Medicine: From Bench to Business” at GTC’s 8th Stem Cell Summit (April 19-20, 2012 in Boston, MA)

Devyn M. Smith, Chief Operating Officer, Neusentis Research Unit at Pfizer to give a Keynote Presentation on “The Dating Game: Finding the Right Partner” at GTC’s 8th Stem Cell Summit (April 19-20, 2012 in Boston, MA).

GTC is pleased to announce three Keynote speakers at the Biomarker Summit 2012, March 15-16 in San Diego, CA. Drs. Carolyn Compton, Steven J. Skates and Khusru Asadullah will present during the Summit plenary session.